SCHEMBL23920375

SCHEMBL23920375

O=C(NC1CCC(NC(=O)C2Cc3ccncc3O2)CC1)c1nc2ccc(Cl)cc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 7/20 0.42
▸ HRH3 Q9Y5N1 2/20 0.42
▸ LMNA P02545 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ SMYD3 Q9H7B4 2/20 0.39
▸ ALOX15 P16050 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ USP30 Q70CQ3 1/20 0.37
▸ NAMPT P43490 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ AOC3 Q16853 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920220 0.88 GLS (0.46) HRH4HRH3LMNAL3MBTL1POLB
SCHEMBL23920267 0.83 ATF4 (0.42) SMYD3NAMPTCYP1A2CYP3A4CYP2C9
SCHEMBL23920263 0.81 GLS (0.51) NAMPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL23920380 0.79 MAOB (0.41) LMNASMYD3CYP1A2CYP3A4CYP2C9
SCHEMBL23920219 0.79 CHRNA7 (0.47) HRH4LMNAPOLBNAMPTCYP1A2
SCHEMBL23920262 0.77 HDAC1 (0.38) SMYD3NAMPTCYP1A2CYP3A4CYP2C9
SCHEMBL23920627 0.72 RAB9A (0.48) HRH4HRH3LMNAL3MBTL1POLB
SCHEMBL23920477 0.70 POLB (0.49) HRH4HRH3LMNAL3MBTL1POLB
SCHEMBL23920621 0.69 KMT2A (0.58) LMNAL3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL19902482 0.68 SMYD3 (0.45) HRH4HRH3LMNAL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047589-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2023-02-16 — — US disclosed
US-11230542-B2 Inhibitors of integrated stress response pathway Praxis Biotech LLC (US) 2022-01-25 — — US disclosed
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2021-10-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 HRH4 1989/4885HRH3 3313/4885LMNA 4459/4885
US-11230542-B2 Inhibitors of integrated stress response pathway ATF4, DDIT3, ATF1 HRH4 1989/4885HRH3 3313/4885LMNA 4459/4885
US-20230047589-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 HRH4 1989/4885HRH3 3313/4885LMNA 4459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback